Daniela Salvemini

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Traumatic Brain Injury

Chemotherapy Induced

Spinal Cord Injury

Top Venues

Journal of neuroinflammation

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

The Journal of pharmacology and experimental therapeutics

Cellular and molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandeep K Singh, Cynthia Weigel, Ryan D R Brown, Christopher D Green, Connor Tuck, Daniela Salvemini, Sarah Spiegel
FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (15) (2024)
Sandeep K Singh, Cynthia Weigel, Ryan D R Brown, Christopher D Green, Connor Tuck, Daniela Salvemini, Sarah Spiegel
FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (15) (2024)
Kathryn Braden, Michela Campolo, Ying Li, Zhoumou Chen, Timothy M Doyle, Luigino Antonio Giancotti, Emanuela Esposito, Jinsong Zhang, Salvatore Cuzzocrea, Christopher Kent Arnatt, Daniela Salvemini
Activation of GPR183 by 7 α ,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through Mitogen-Activated Protein Kinase and Nuclear Factor- κ B. The Journal of pharmacology and experimental therapeutics 383 (2) (2022)
Filomena Lauro, Luigino Antonio Giancotti, Grant Kolar, Caron Mitsue Harada, Taylor A Harmon, Timothy J Garrett, Daniela Salvemini
Role of Adenosine Kinase in Sphingosine-1-Phosphate Receptor 1-Induced Mechano-Hypersensitivities. Cellular and molecular neurobiology (2021)
Susan A Farr, Salvatore Cuzzocrea, Emanuela Esposito, Michela Campolo, Michael L Niehoff, Timothy M Doyle, Daniela Salvemini
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury. Journal of neuroinflammation 17 (1) (2020)
Timothy M Doyle, Mark R Hutchinson, Kathryn Braden, Kali Janes, Vicky Staikopoulos, Zhoumou Chen, William L Neumann, Sarah Spiegel, Daniela Salvemini
Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents. Journal of neuroinflammation 17 (1) (2020)